Experimental Ebola drug ZMapp begins clinical trials in Liberia
Friday, February 27, 2015 - 19:30
in Health & Medicine
ZMapp, the experimental Ebola drug that won notoriety when it was given to a handful of infected aid workers at the height of the epidemic, will now begin clinical testing in Liberian treatment centers, U.S. health authorities said.